Which of the following structures contains baroreceptors that detect changes in blood pressure?
Inotropic effect of thyroid hormone is by ?
Aortic valve closure corresponds to the beginning of which phase of the cardiac cycle?
Inhibition of heart by vagus is mediated by which receptors?
Which of the following conditions can lead to a decrease in afterload?
What is the mechanism by which M2 receptors mediate the inhibition of the heart by the vagus nerve?
What is the typical oxygen saturation level of venous blood?
Cerebral blood flow is most directly increased by?
Coronary steal phenomenon caused due to
What is the critical closing pressure in the context of capillary physiology?
Explanation: ***Carotid sinus*** - The **carotid sinus** is a dilation at the bifurcation of the common carotid artery, containing **baroreceptors** sensitive to changes in blood pressure [1]. - These baroreceptors are **mechanoreceptors** that respond to the stretching of the vessel wall due to increased arterial pressure, sending signals to the brainstem to regulate blood pressure. *Carotid body* - The **carotid body** is a chemoreceptor that primarily detects changes in **blood oxygen, carbon dioxide, and pH** levels, not blood pressure [2]. - It plays a crucial role in regulating **respiration** in response to hypoxemia. *Aortic body* - The **aortic body** is a **chemoreceptor** located near the aortic arch that primarily monitors **blood oxygen, carbon dioxide, and pH levels**. - Note: While the aortic body itself is a chemoreceptor, the **aortic arch** (a different structure) does contain baroreceptors [1]. However, this option specifically refers to the aortic body, which is not a baroreceptor. - The aortic body contributes to the regulation of **respiration** in response to hypoxemia, not directly blood pressure. *None of the options* - This option is incorrect because the **carotid sinus** is a well-known site for baroreceptors involved in blood pressure regulation.
Explanation: ***Enhancement of Catecholamines*** - Thyroid hormones **potentiate the effects of catecholamines** (like adrenaline and noradrenaline) on the heart, leading to increased heart rate and contractility, which is an **inotropic effect**. - This occurs by increasing the number and sensitivity of **beta-adrenergic receptors** on cardiac muscle cells. *Membrane receptors* - While thyroid hormones do have some rapid, non-genomic effects that may involve **membrane receptors**, their primary and well-established inotropic effect is mediated indirectly through catecholamine sensitivity. - The classic action of thyroid hormones is via intracellular receptors that modulate gene expression, not direct membrane receptor signaling for inotropic effects. *cAMP* - **cAMP** is a common second messenger for many hormones, particularly those acting via G protein-coupled receptors. - While catecholamines themselves act through cAMP to exert their cardiac effects, thyroid hormones *enhance the action* of catecholamines rather than directly using cAMP as their primary inotropic mechanism. *cGMP* - **cGMP** is a second messenger often associated with nitric oxide signaling and vasodilation, contributing to cGMP-dependent protein kinases. - It is not the primary mediator for the *positive inotropic effect* of thyroid hormones on the heart.
Explanation: ***Isovolumetric relaxation*** - **Aortic valve closure** marks the end of **ventricular ejection** and the beginning of **isovolumetric relaxation** as both the aortic and mitral valves are closed, and ventricular pressure drops without a change in volume. - This phase is vital for the heart to relax and prepare for filling, corresponding to the **second heart sound (S2)**. *Systole* - **Systole** refers to the **contraction phase** of the heart, encompassing both isovolumetric contraction and ventricular ejection. - Aortic valve closure signifies the end of the **ejection phase** of systole, not its beginning. *Parasystole* - **Parasystole** is an **arrhythmia** where an ectopic pacemaker competes with the normal sinus rhythm, leading to independent atrial or ventricular contractions. - It is a **pathological condition** and not a normal phase of the cardiac cycle. *Isovolumetric contraction* - **Isovolumetric contraction** occurs after the **mitral valve closes** and before the aortic valve opens, causing pressure to build in the ventricle. - This phase precedes **ventricular ejection** and is initiated by mitral valve closure, not aortic valve closure.
Explanation: ***M2*** - The **vagus nerve** primarily mediates its inhibitory effects on the heart through **muscarinic M2 receptors**. - Activation of M2 receptors by **acetylcholine** (released from the vagus nerve) decreases heart rate and contractility. *M1* - **M1 receptors** are primarily found in neuronal tissue and glands, playing a role in **gastric acid secretion** and cognitive functions. - They are not the primary muscarinic subclass responsible for vagal inhibition of the heart. *NN* - **NN receptors** are **nicotinic receptors** found on postganglionic neurons in autonomic ganglia. - They are involved in **ganglionic transmission** and are not directly responsible for efferent vagal effects on the heart. *NM* - **NM receptors** are **nicotinic receptors** found at the **neuromuscular junction** of skeletal muscles. - Their activation leads to **skeletal muscle contraction**, and they have no role in regulating heart function.
Explanation: ***Severe anemia*** - In **severe anemia**, the **blood viscosity** is reduced, and the body compensates by decreasing systemic vascular resistance to maintain tissue perfusion, thereby lowering **afterload**. - The reduced **oxygen-carrying capacity** triggers vasodilation to maximize blood flow to tissues, contributing to decreased afterload. - This represents a **chronic compensatory mechanism** that results in sustained reduction of afterload. *Hypothyroidism* - **Hypothyroidism** typically leads to an **increase in systemic vascular resistance** and thus can increase afterload. - It often results in **bradycardia** and reduced cardiac output, which can further elevate afterload to maintain pressure. *Increased physical activity* - During **physical activity**, there is **vasodilation in exercising muscles**, which acutely decreases systemic vascular resistance. - However, this is accompanied by **increased cardiac output** and **elevated blood pressure** due to sympathetic stimulation, and the afterload reduction is **transient** rather than sustained. - In the context of this question asking about conditions that lead to decreased afterload, **severe anemia** is the better answer as it represents a chronic pathological state with sustained afterload reduction, whereas exercise represents a temporary physiological response. *None of the options* - This option is incorrect because **severe anemia** is a recognized cause of decreased afterload.
Explanation: ***Inhibition of adenylate cyclase*** - M2 receptors are **Gαi-protein coupled receptors**, and their activation leads to the inhibition of **adenylate cyclase**. - This inhibition reduces the intracellular concentration of **cAMP**, which in turn decreases the activity of **protein kinase A (PKA)**, leading to a decrease in heart rate and contractility. - Additionally, M2 receptors activate **inwardly rectifying potassium channels (IKACh)**, which hyperpolarizes the cell membrane and further slows heart rate. *Activation of phospholipase C* - This mechanism is characteristic of **M1 and M3 muscarinic receptors (Gq-coupled)**, which activate phospholipase C, leading to increased IP3 and DAG. - This pathway is primarily involved in smooth muscle contraction and glandular secretion, not direct cardiac inhibition by M2 receptors. *Inhibition of cAMP breakdown* - Inhibition of **cAMP breakdown** would lead to an increase in cAMP levels, which would stimulate cardiac function. - This effect is mediated by drugs like **phosphodiesterase inhibitors**, which block the enzyme responsible for cAMP degradation, and is opposite to the effect of M2 receptor activation. *Opening of voltage-gated calcium channels* - Opening of voltage-gated calcium channels would **increase** calcium influx, leading to increased contractility and heart rate. - This is the mechanism of action of **sympathetic stimulation via β1-adrenergic receptors**, not parasympathetic M2 receptor activation, which has the opposite effect.
Explanation: ***70%*** - Venous blood has a lower oxygen saturation compared to arterial blood because tissues have extracted a significant amount of oxygen for **cellular respiration**. - A typical mixed venous oxygen saturation (SvO2) is around **70-75%**, indicating the amount of oxygen remaining after tissues have taken what they need. *30%* - This level of oxygen saturation is **too low** for typical venous blood and would indicate severe tissue hypoperfusion or extreme oxygen extraction. - Such low levels are usually not compatible with normal physiological function for prolonged periods. *50%* - While lower than normal, a 50% venous oxygen saturation is still indicative of **increased oxygen extraction** by tissues, often seen in conditions of increased metabolic demand or decreased oxygen delivery. - It's not the typical resting value for healthy individuals. *90%* - An oxygen saturation of 90% is more characteristic of **arterial blood** (normal arterial saturation is 95-100%). - Venous blood, having already delivered oxygen to tissues, would normally have a lower saturation.
Explanation: ***Increase in PCO2*** - An increase in **arterial PCO2** (partial pressure of carbon dioxide) causes **cerebral vasodilation**, leading to a direct increase in cerebral blood flow. - This is a potent regulatory mechanism to ensure adequate **carbon dioxide removal** and **oxygen supply** to the brain. *Increase in PO2* - An increase in **arterial PO2** (partial pressure of oxygen) causes **mild cerebral vasoconstriction**, which would tend to decrease cerebral blood flow, not increase it. - Cerebral blood flow is generally **less sensitive** to changes in PO2 within the normal range compared to PCO2. *Decrease metabolic rate* - A decrease in the brain's **metabolic rate** would typically lead to a **decrease in local demand** for oxygen and nutrients, resulting in **decreased cerebral blood flow**. - Cerebral blood flow is intrinsically linked to the metabolic needs of brain tissue. *Increase in metabolic rate* - An increase in the brain's **metabolic rate** would lead to an **increase in demand** for oxygen and glucose, which in turn causes **vasodilation** and an increase in cerebral blood flow. - However, this is an indirect effect, whereas an increase in PCO2 directly causes vasodilation.
Explanation: ***Preferential vasodilation of normal coronary vessels over stenotic vessels*** - In a coronary steal phenomenon, **vasodilator drugs** or agents cause **normal coronary arteries** to dilate significantly. - This increased flow in normal areas *diverts blood away* from areas supplied by **stenotic vessels**, leading to **ischemia** in the compromised regions. *Dilation of large coronary arteries* - While large coronary arteries can dilate, this alone does not fully explain the steal phenomenon. The critical factor is the *unbalanced dilation* between healthy and stenotic regions. - Most pharmacological agents used to induce steal, like **dipyridamole** or **adenosine**, primarily affect the **resistance arterioles**. *Dilation of epicardial coronary vessels* - **Epicardial coronary vessels** are the larger conductive arteries, and their dilation does not directly cause the steal phenomenon. - The steal occurs at the level of the **microvasculature**, where resistance is regulated and blood flow away from ischemic areas is diverted. *Dilation of capacitance vessels* - **Capacitance vessels** (mainly veins) store blood but do not play a significant direct role in regulating coronary blood flow or causing the coronary steal phenomenon. - The phenomenon is driven by changes in **arteriolar resistance** and distribution of flow.
Explanation: ***Pressure below which capillaries close*** - The **critical closing pressure** is the lowest pressure at which blood can flow through a capillary. - When the luminal pressure falls below this threshold, the capillary collapses due to **extrinsic tissue pressure** and intrinsic vascular tone. *Arterial pressure minus venous pressure* - This calculation represents the **arteriovenous pressure gradient**, which drives blood flow through a vascular bed. - It does not directly define the point at which capillaries collapse. *Capillary pressure minus venous pressure* - This difference primarily influences filtration and reabsorption of fluids across the capillary wall. - It is not directly related to the **critical closing pressure** of the capillaries. *None of the options* - This is incorrect as one of the provided options accurately defines the **critical closing pressure**.
Cardiac Electrophysiology
Practice Questions
Cardiac Cycle
Practice Questions
Cardiac Output and Its Regulation
Practice Questions
Hemodynamics and Blood Flow
Practice Questions
Arterial System Physiology
Practice Questions
Microcirculation and Lymphatics
Practice Questions
Venous Return and Central Venous Pressure
Practice Questions
Cardiovascular Reflexes
Practice Questions
Regional Circulations
Practice Questions
Cardiovascular Responses to Exercise and Stress
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free